Please check your internet connection and try again.
# Potassium Chloride
## Overview
Potassium chloride (KCl) is an essential electrolyte used to prevent and treat hypokalemia. It is available in oral and intravenous formulations.
## Primary Indications
* Treatment and prevention of hypokalemia.
## Adult Dosing
* **Prevention of hypokalemia:** Typically 20-40 mEq per day orally, divided into 1-2 doses.
* **Treatment of hypokalemia:** 40-100 mEq per day orally, divided into 2-4 doses. Serum potassium levels and clinical status will guide duration and dosage.
* **Intravenous (IV):** Dosing depends on serum potassium level, patient condition, and presence of EKG changes. Maximum infusion rates and concentrations are critical to prevent cardiac toxicity. **Generally, do not exceed 10 mEq/hour IV infusion rate in non-monitored patients, and typically no more than 20 mEq/hour in monitored patients.** Total daily dose usually does not exceed 200 mEq. **Specific IV dosing protocols often vary by institution.**
## Pediatric Dosing
* **Prevention of hypokalemia:** 1-2 mEq/kg/day orally, divided into 2-4 doses. Maximum daily dose is typically 40 mEq.
* **Treatment of hypokalemia:** 2-5 mEq/kg/day orally, divided into 2-4 doses. Maximum daily dose is typically 40 mEq.
* **Intravenous (IV):** Dosing is highly individualized based on serum potassium, age, weight, and clinical status. **Follow institutional guidelines or consult with a pediatric specialist.** Maximum infusion rates and concentrations are essential.
## Dose Adjustments
* **Renal Impairment:** Use with extreme caution. Dosage reduction is typically necessary due to impaired potassium excretion. Monitor serum potassium closely.
## Contraindications
* Hyperkalemia.
* Conditions that predispose to hyperkalemia (e.g., severe renal impairment, untreated Addison's disease, certain medications).
* Gastrointestinal obstruction or delay in transit.
## Adverse Effects
* **Common:** Nausea, vomiting, abdominal discomfort, diarrhea.
* **Serious:** Hyperkalemia (can be life-threatening, presenting with muscle weakness, paresthesias, cardiac arrhythmias, cardiac arrest), GI ulceration, bleeding, or perforation (especially with sustained-release oral formulations).
## Key Drug Interactions
* **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene), ACE inhibitors, ARBs, NSAIDs, cyclosporine, tacrolimus:** Increased risk of hyperkalemia.
* **Anticholinergics:** May increase risk of GI ulceration with oral KCl.
* **Sodium polystyrene sulfonate:** Used to treat hyperkalemia; monitor for electrolyte imbalances.
## Monitoring
* **Serum potassium levels:** Frequent monitoring is crucial, especially during initiation, dose changes, and in patients with renal impairment or risk factors for hyperkalemia.
* **Renal function (BUN, creatinine).**
* **EKG:** Especially with IV administration or if hyperkalemia is suspected.
* **Signs and symptoms of hypokalemia and hyperkalemia.**
## Clinical Pearls
* Oral potassium chloride should be taken with meals or a full glass of water to minimize GI irritation.
* Sustained-release formulations may reduce GI side effects but carry a higher risk of localized ulceration.
* IV potassium chloride must be administered slowly and diluted to prevent potentially fatal cardiac arrhythmias. **Never administer IV KCl undiluted as a bolus.**
* Hypokalemia can be exacerbated by diuretics, corticosteroids, and vomiting/diarrhea.
***
*Disclaimer: This information is intended for clinical decision support and does not replace the need to consult the official prescribing information and current clinical guidelines. Always verify the most up-to-date drug information before making any clinical decisions.*
